| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| Rigosertib |
➤ Sign Up |
Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders |
Temple University - Of the Commonwealth System of Higher Education (Philadelphia, PA) Onconova Therapeutics, Inc. (Newtown, PA) |
➤ Sign Up |
| Rigosertib |
➤ Sign Up |
Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones |
Onconova Therapeutics, Inc. (Newtown, PA) |
➤ Sign Up |
| Rigosertib |
➤ Sign Up |
Composition and methods for the treatment of proliferative diseases |
Temple University - Of The Commonwealth System of Higher Education (Philadelphia, PA) Mount Sinai School of Medicine (New York, NY) |
➤ Sign Up |
| Rigosertib |
➤ Sign Up |
Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis |
Temple University--Of The Commonwealth System of Higher Education (Philadelphia, PA) Onconova Therapeutics, Inc. (Newtown, PA) |
➤ Sign Up |
| Rigosertib |
➤ Sign Up |
Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones |
Temple University--Of The Commonwealth System of Higher Education (Philadelphia, PA) Onconova Therapeutics, Inc. (Newtown, PA) |
➤ Sign Up |
| Rigosertib |
➤ Sign Up |
Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkoxystyryl 4-substituted benzylsulfones |
Onconova Therapeutics, Inc (Newtown, PA) |
➤ Sign Up |
| Rigosertib |
➤ Sign Up |
Composition and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia |
Temple University--Of the Commonwealth System of Higher Education (Philadelphia, PA) Icahn School of Medicine at Mount Sinai (New York, NY) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
